Voluntary Assisted Dying (VAD) is entering a new phase in Australia. With VAD legislation now enacted in every Australian jurisdiction, including most recently the Northern Territory, the focus is beginning to shift from legislative reform and service establishment toward long-term service optimisation. As programs mature, increasing attention is being directed toward clinical standards, integration with palliative care, equitable regional access, workforce sustainability and the evidence base required to support future service development.
This presentation will provide a brief overview of the current VAD landscape in Australia before exploring the next phase of service development. Drawing on emerging evidence, Australian experience, and key learnings from the 2026 VADANZ Conference, attendees will gain insight into future directions for VAD pharmacy practice and the role pharmacists can play in shaping high-quality, patient-centred and sustainable VAD services.
This presentation will address the following learning objectives: